Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-17 11:32:24 EDT

PhotosVideosAllPeople
LatestRanked
@pharmalot.bsky.socialOct 16, 2026, 2:38 PM

Up and Down the Ladder: Job Changes.. the latest comings & goings.. recognize anyone? statnews.com/pharmalot/20... #pharma #biotech #jobs #Gilead #Sanof

@politicsdaily.bsky.socialOct 16, 2026, 2:33 PM

Trump’s pharma holdings surged from $1.7 million in 2024 to $56.2 million in 2025 - Fortune #Trump #Pharma #Healthcare #StockMarket #Medicare

@pharmalot.bsky.socialOct 16, 2026, 2:28 PM

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more news.. statnews.com/pharmalot/20... #pharma #Trump #peptides #obesity #weight #Lilly #China #biotech #FDA #340B

@politicsdaily.bsky.socialOct 16, 2026, 12:13 PM

Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say - WRAL #Trump #Medicare #Pharma #Healthcare #Investments

@drtimos.bsky.socialOct 16, 2026, 11:55 AM

Signal or noise? > Jyong Biotech Announces Proposed Texas Facility to Support
Potential Commercialization of Its Drug Candidates - Yahoo
Finance >> Comment below! #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #healthcare #pharma #pharmaceutical

@abangelabs.bsky.socialOct 16, 2026, 11:05 AM

Australia recommends broader subsidy access across 14 low-cost antidepressants—what PBAC’s move means for access and HTA. https://www.mattheneus.com/editorial/pbac-fourteen-antidepressants-subsidy-restriction-relaxation-2026-10-16 #HTA #Pharma #RegulatoryAffairs

@larisa13.bsky.socialOct 16, 2026, 8:13 AM

Digital twins are transforming pharma manufacturing with virtual replicas that help optimize production, improve quality, predict equipment issues, and support compliance. Discover how this technology is reshaping pharma: blogs.yuktra.ai/digital-twin...

#DigitalTwin #Pharma

@4040rec.bsky.socialOct 16, 2026, 8:05 AM

#FridayFeeling #FridayVibes #FridayMotivation #fridaymorning #Friday #4040rec #medicalsales #marketing #marketaccess #leadership #recruitment #talentacquisition #UKJobs #medicalequipment #medicalconsumables #medicaldevices #pharma #healthcare #biotech #medtech #lifesciences #healthcaresales

Photo, no description
@drtimos.bsky.socialOct 16, 2026, 7:58 AM

🚀 #DigitalHealth | #AI | #IoE 🌐
At #LucidQuest, we turn bold ideas into patient-centric, AI-powered solutions for #Pharma, #Biotech & #HealthTech.
Let’s shape the future of care together.
📩 [email protected] or

@abangelabs.bsky.socialOct 16, 2026, 7:05 AM

A direct survival gain underpins Europe’s positive opinion for Rasonque in metastatic pancreatic cancer. https://www.mattheneus.com/editorial/ema-rasonque-metastatic-pancreatic-adenocarcinoma-chmp-opinion-2026-10-15 #HTA #Pharma #RegulatoryAffairs

@abangelabs.bsky.socialOct 16, 2026, 7:04 AM

No evidence submission, no recommendation: Scotland withholds oral Wegovy for weight management. https://www.mattheneus.com/editorial/smc-oral-wegovy-semaglutide-tablets-weight-management-non-submission-2026-10-12 #HTA #Pharma #RegulatoryAffairs

@midgardfinance.comOct 16, 2026, 7:00 AM

💉 #pharma #immunology

🇨🇭 $RO: FDA approved #Enspryng for thyroid eye disease, a home injection every four weeks, against eight IV infusions of 🇺🇸 $AMGN's #Tepezza.

Tepezza sold €495m in Q2, Enspryng €108m in all its uses. One of its two TED trials missed.

midgardfinance.com/companies/ROP.SW/

Line chart titled "Tepezza and Enspryng quarterly sales", worldwide sales per quarter in euros from Q1 2024 to Q2 2026, axis marked 0 to 600 million euros. The violet Tepezza line, Amgen's thyroid eye disease drug, moves between about €362m and €495m a quarter, from €390m to €495m. The light blue Enspryng line, Roche's, sits far below it and climbs slowly from €69m to €108m, about a fifth of Tepezza in the last quarter.
@mmxviii.bsky.socialOct 15, 2026, 9:34 PM

Naptime with Pharma - Came across the naptime video on insta and suddenly had the idea to pair it with pharma. This was a fun one to work on #transformers #maccadams #3dmodel #transformersidw #tfidw #robot #blender #blenderanimation #3danimation #pharma #idwpharma #mtmte #blender3d #animationmeme

@brukercorporation.bsky.socialOct 15, 2026, 8:00 PM

See you at AAPS 2026 PharmSci 360 on October 25-28 in New Orleans, LA. We'll be at booth 1219!
Learn more: https://goto.bruker.com/4sgFo8r

We look forward to seeing you!

#DrugDevelopment #Pharma #PharmaIndustry

Photo, no description
@drtimos.bsky.socialOct 15, 2026, 7:25 PM

Signal or noise? > Fifty per cent of eight: Verastem takes VS-7375 to phase
3 >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #healthcare #biotech #pharmaceutical

@abangelabs.bsky.socialOct 15, 2026, 7:05 PM

The UK regulator is strengthening antidepressant warnings on suicide risk and persistent sexual dysfunction, sharpening patient safeguards. https://www.mattheneus.com/editorial/mhra-antidepressant-suicide-pssd-patient-information-safeguards-2026-10-15 #HTA #RegulatoryAffairs #Pharma

@pharmaphorum.bsky.socialOct 15, 2026, 3:38 PM

In today’s headlines: pharmaphorum.com/news #news #pharma #lifesciences #pharmanews #pharmaindustry

@midgardfinance.comOct 15, 2026, 3:00 PM

📊 #pharma

🇩🇰 Novo Nordisk put 26% of revenue into building capacity in the year to June 2026. 🇺🇸 Eli Lilly put 10%.

That is 63% of Novo's operating cash flow going into factories.

midgardfinance.com/research/lilly/

$NOVO $LLY

Line chart of capital spending as a share of revenue for Novo Nordisk and Eli Lilly, each point a rolling four quarters, from 2016 to the twelve months ended June 2026. Year-end readings: Novo Nordisk: 2016 7%, 2017 8%, 2018 11%, 2019 9%, 2020 17%, 2021 5%, 2022 8%, 2023 17%, 2024 18%, 2025 29%. Eli Lilly: 2016 5%, 2017 6%, 2018 14%, 2019 6%, 2020 8%, 2021 7%, 2022 10%, 2023 22%, 2024 18%, 2025 12%. Both sat near 6 to 11 per cent before 2023. Novo's line then climbs to 26% for the twelve months to June 2026, 15 percentage points above Lilly's 10%, and its capital spending is 63% of operating cash flow over the same period. A ratio is used rather than money because the two report in different currencies. Novo's purchase of manufacturing sites from Catalent is not in these figures, which cover plant and equipment only.
@pharmalot.bsky.socialOct 15, 2026, 1:57 PM

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more news.. statnews.com/pharmalot/20... #pharma #FDA #AI #AstraZeneca #DOGE #cancer #vaccine #weight #obesity #SouthAfrica #Roche #schizophrenia

@abangelabs.bsky.socialOct 15, 2026, 11:04 AM

Scotland withheld an acalabrutinib recommendation—not over negative evidence, but because no company submission was made. https://www.mattheneus.com/editorial/smc-acalabrutinib-monotherapy-relapsed-refractory-mcl-non-submission-2026-10-12 #HTA #RegulatoryAffairs #Pharma

Load more